Skip to main content

GlaxoSmithKline to buy California biotech firm Sierra Oncology for $1.9B

The San Mateo-based biotech company is focused on developing treatments for rare types of cancer.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.